← Open Payments lookup

SUSAN MORPHIS: Open Payments

NPI 1952825572 · DELHI, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,007 in 53 payments from 11 companies in 2025. Trend: 2023 $1,260 · 2024 $817 · 2025 $1,007

Food & beverage: $1,007
CompanyPaymentsAmount
Axsome Therapeutics, Inc.13$348
Otsuka America Pharmaceutical, Inc.10$171
ABBVIE INC.11$144
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$117
Alkermes, Inc.3$49
E.R. Squibb & Sons, L.L.C.3$46
Corium, LLC3$44
Neurocrine BioSciences, Inc.1$33
Vanda Pharmaceuticals Inc.1$21
Lundbeck LLC1$21

Products named: Auvelity, REXULTI, VRAYLAR, CAPLYTA, ARISTADA, COBENFY, Azstarys, INGREZZA.

Industry payments across LA — which companies pay providers there.